Q2 2022 Vivoryon Therapeutics NV Earnings Call Transcript

Sep 30, 2022 / 01:00PM GMT
Operator

Good day, ladies and gentlemen, and welcome to the Vivoryon Therapeutics Half Year Results for 2022.

Information in today's conference is being recorded. And at this time, I will turn the call over to your host today, Ms. Manuela Bader. Please go ahead, ma'am.

Manuela Bader - Vivoryon Therapeutics N.V. - Director of IR & Communications

Thank you, George. Good afternoon, and thank you for joining us today for Vivoryon's conference call to discuss the company's first half 2022 results and operational progress today, including details on the (inaudible) we announced earlier this morning. This morning, Vivoryon issued a press release reporting its first half 2022 results. This is posted on the company's website at www.vivoryon.com.

On the call with me today are Uli Dauer, our Chief Executive Officer of Vivoryon; and Florian Schmid, our Chief Financial Officer. Also with us on today's call and available for questions is Michael Schaeffer, our Chief Business Officer. We will begin

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot